Cimoxatone

Last updated
Cimoxatone
Cimoxatone structure.svg
Clinical data
ATC code
  • none
Identifiers
  • 3-[[4-[5-(methoxymethyl)-2-oxo-oxazolidin-3-yl]phenoxy]methyl]benzonitrile
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.070.537 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C19H18N2O4
Molar mass 338.363 g·mol−1
  • InChI=1S/C19H18N2O4/c1-23-13-18-11-21(19(22)25-18)16-5-7-17(8-6-16)24-12-15-4-2-3-14(9-15)10-20/h2-9,18H,11-13H2,1H3 Yes check.svgY
  • Key:MVVJINIUPYKZHR-UHFFFAOYSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Cimoxatone (MD 780515) is a reversible inhibitor of MAO-A (RIMA). [1] It was never marketed.

Cimoxatone has a half-life of 12.4 hours in humans. [2]

See also

References

  1. ↑ Nair NP, Ahmed SK, Kin NM, West TE (1995). "Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients". Acta Psychiatr Scand Suppl . 386: 28–35. doi:10.1111/j.1600-0447.1995.tb05921.x. PMID   7717092. S2CID   9100689.
  2. ↑ "Cimoxatone: pharmacokinetics of various formulations". InPharma. 427 (1): 6–6. 1984-03-01. doi:10.1007/BF03314342. ISSN   2230-6056.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.